+Vote!
Star Tribune (Free subscription) | 07/24/2008
Boston Sci payout to Medtronic amended Medtronic Inc., the Fridley maker of heart devices, agreed that a $250 million patent-infringement verdict won against Boston Scientific Corp. should be cut by almost $64 million, because a judge threw out part of the decision. The two companies agreed on the reduction after a federal judge in Texas said there was "no legally sufficient" basis for a jury to find...
+Vote!
Dr. Wes (Free subscription) | 07/23/2008
In-pharma Technologist.com has a good review of the Wyeth v. Levine case before the Supreme Court that, like the Riegel v Medtronic case for the medical device industry, will rule if FDA approval of pharmaceutical manufacturing and labeling processes would preempt state liability claims from the recent digitek (digoxin) and heparin manufacturing problems. -Wes Musings of a cardiologist and cardiac...
+Vote!
Drug and Device Law (Free subscription) | 07/21/2008
Northwestern University Law Review's Colloquy site has published the first installment of Catherine Sharkey's extended "essay post" on what Riegel v. Medtronic portends for FDA preemption. Here's a link . Professor Sharkey proposes "that, when trying to determine whether or not state law should be preempted by federal agency action, courts should look to the regulatory record to determine whether or...
+Vote!
Star Tribune (Free subscription) | 07/18/2008
Spineology Inc. said Monday that it has raised $7.5 million from a private placement. The St. Paul-based maker of devices used in spine surgeries will use the money to expand distribution, conduct clinical research, and develop new products. The financing was led by Minneapolis-based Oakridge Financial. The company did not disclose the new investors. “We’re at a [...]
+Vote!
The Minneapolis/St. Paul Business Journal (Free subscription) | 07/18/2008
Medtronic will cut 37 jobs as it closes its acquisition of Restore Medical. (MDT)
+Vote!
Red Orbit (Free subscription) | 07/18/2008
Medtronic, Inc. (NYSE:MDT) today announced that it has completed its acquisition of Restore Medical, Inc. (NASDAQ: REST). Under the terms of the agreement announced on April 22, 2008, Restore shareholders will receive $1.60 per share in cash for each share of Restore common stock they own.
+Vote!
Medical News Today (Free subscription) | 07/16/2008
Medtronic, Inc. (NYSE: MDT) announced it has received Japanese regulatory approval for the Reveal DX™ Insertable Cardiac Monitor (ICM). The device has been designated by the Japanese government as a high-priority medical device, and is the first insertable cardiac monitor to be introduced in Japan. The Reveal DX ICM provides insight into unexplained fainting episodes, also known as syncope.
+Vote!
The Minneapolis/St. Paul Business Journal (Free subscription) | 07/15/2008
Medtronic Inc. won approval in Asia on an implantable heart device that treats unexplained fainting episodes. (MDT)
+Vote!
PR News Wire (Free subscription) | 07/15/2008
MINNEAPOLIS, July 15 /PRNewswire/ --
Event: Medtronic Celebration of Courage Gala
Date: Saturday, Sept. 13, 2008
Time: Sponsor Champagne Reception begins at 5:30 p.m.
Cocktail Hour begins at 6 p.m.
Dinner begins at 7 p.m.
Silent and live auction throughout the evening
Where: The Depot
225 Third Avenue South
Minneapolis, Minnesota
Complimentary on-site parking available
This yearly event...
+Vote!
Business Wire (Free subscription) | 07/15/2008
MINNEAPOLIS & TOKYO--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced it has received Japanese regulatory approval for the Reveal DX™ Insertable
+Vote!
Business Wire (Free subscription) | 07/14/2008
MINNEAPOLIS--(BUSINESS WIRE)--The Medtronic Foundation and Twin Cities Marathon, Inc., today announced former Olympian and marathon world record holder Alberto Salazar will serve as
+Vote!
Drug and Device Law (Free subscription) | 07/14/2008
We've said it before , and we'll say it again: Plaintiffs will now regularly plead that their state law claims against device manufacturers run "parallel" to the FDA's requirements and so are not preempted under Riegel v. Medtronic , 128 S. Ct. 999 (2008). And we've said it before, and we'll say it again: We think that's wrong . We're not sure that this purported loophole to Riegel even exists; if...
+Vote!
Star Tribune (Free subscription) | 07/11/2008
Edwards Lifesciences Corp., the maker of a heart valve implanted without chest-splitting surgery, may be a ripe acquisition target for the world's two biggest device makers, including Medtronic Inc., analysts say.Medtronic, however, says it isn't interested.Johnson & Johnson of New Brunswick, N.J., and Medtronic, based in Fridley, announced plans within four days of each other last month to enter the...
